Neurotoxin

Global Botulinum Toxin Market Forecast to 2028 - by Product Type, Application, and End User - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 16, 2022

The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.
  • The botulinum toxin market is expected to reach US$ 8,977.62 million by 2028 from US$ 5,307.71 million in 2021.
  • The factors responsible for the botulinum toxin market's growth are increasing aesthetic procedures and the use of botulinum toxin, and the rising number of non-invasive cosmetic procedures.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.

Appiell Announces Results of Pilot Study of its Digital Platform for Aesthetics and Dermatology Applications

Retrieved on: 
Wednesday, March 9, 2022

PLANO, Texas, March 9, 2022 /PRNewswire/ -- Appiell, a privately-held, early-stage digital health company, today announced topline results of its pilot study showcasing the efficiency and functionality of its artificial intelligence (AI) platform.

Key Points: 
  • PLANO, Texas, March 9, 2022 /PRNewswire/ -- Appiell, a privately-held, early-stage digital health company, today announced topline results of its pilot study showcasing the efficiency and functionality of its artificial intelligence (AI) platform.
  • The study achieved its objectives and confirmed consistency and objectivity in the assessment of rhytids in patients with glabellar frown lines.
  • There was also inconsistency between individual physicians' own grading of the same GFL photos at different passes (78%).
  • As we previously remarked, the results from this study are important in addressing significant unmet needs of the key stakeholders in the aesthetics sector.

Defunkify is exposing the dirty business of cover-up scents in the laundry detergent industry

Retrieved on: 
Wednesday, March 9, 2022

The sad truth is that a large number of cleaning products and laundry detergents are produced with hazardous ingredients .

Key Points: 
  • The sad truth is that a large number of cleaning products and laundry detergents are produced with hazardous ingredients .
  • There are a number of ingredients within laundry detergents that are toxic and damaging to our health (thorough list outlined below).
  • I want the industry to have tighter regulations on what ingredients can be used in laundry detergents and all cleaning products.
  • Only when consumers are informed can they collectively make a decision to change and bring the industry with them.

New Treatment Saves Sea Turtle Lives

Retrieved on: 
Tuesday, February 22, 2022

The team noted that sea turtles treated with intravenous lipid emulsion (ILE) had improved survival.

Key Points: 
  • The team noted that sea turtles treated with intravenous lipid emulsion (ILE) had improved survival.
  • Red tides are caused by a harmful algal species that releases potent neurotoxins, known as brevetoxins, into the surrounding water.
  • Because of the excellent response noted in sea turtles, ILE has now been used to treat sea birds affected by brevetoxins, with encouraging results.
  • "This study will have a significant positive impact on the treatment of sea turtles affected by red tides," said Dr. Janet Patterson-Kane, Morris Animal Foundation Chief Scientific Officer.

AAFPRS ANNOUNCES ANNUAL SURVEY RESULTS: DEMAND FOR FACIAL PLASTIC SURGERY SKYROCKETS AS PANDEMIC DRAGS ON

Retrieved on: 
Thursday, February 10, 2022

WASHINGTON, Feb. 10, 2022 /PRNewswire/ -- The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) , the world's largest association of facial plastic surgeons, today released its 2021 member survey outcomes .

Key Points: 
  • WASHINGTON, Feb. 10, 2022 /PRNewswire/ -- The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) , the world's largest association of facial plastic surgeons, today released its 2021 member survey outcomes .
  • Despite lingering pandemic concerns, 2021 saw catapulting demand for facial plastic surgery and aesthetic procedures as in-person events and face-to-face socialization resumed.
  • According to AAFPRS members, the total number of surgical and non-surgical facial plastic surgery treatments is up dramatically.
  • The American Academy of Facial Plastic and Reconstructive Surgery is the world's largest specialty association for facial plastic surgery.

Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment

Retrieved on: 
Wednesday, February 9, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220209005461/en/
    Resilience's site in Alachua, Florida, will develop a monoclonal antibody as a medical countermeasure to botulinum neurotoxins for the US Department of Defense.
  • We are proud to support the Department of Defense develop this important medicine to protect the warfighter from exposure to botulinum toxins, said Rahul Singhvi, Sc.D., Chief Executive Officer of Resilience.
  • The contract was awarded by the DODs Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense ( JPEO-CBRND ).
  • Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.

Vensica Closes $19 Million Round with Investment from Strategic Partner Merz

Retrieved on: 
Monday, February 7, 2022

TEL AVIV, Israel, Feb. 7, 2022 /PRNewswire/ -- Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, has closed a $19 million investment round.

Key Points: 
  • TEL AVIV, Israel, Feb. 7, 2022 /PRNewswire/ -- Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, has closed a $19 million investment round.
  • Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica's financing with up to $3 million, bringing the total round to up to $19 million.
  • Merz is the second strategic global company joining this round, following Laborie, a global urology company, that has made two investments in Vensica."
  • Merz Group has the businesses Merz Aesthetics, Merz Therapeutics, Merz Consumer Care, Merz Real Estate and Financial Investments.

Merz Strengthens Partnership With Start-up Vensica and Invests up to $3 million

Retrieved on: 
Monday, February 7, 2022

Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics as the Merz Group invests up to $3 million in the Israeli start-up.

Key Points: 
  • Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica Therapeutics as the Merz Group invests up to $3 million in the Israeli start-up.
  • Vensica is expanding its workforce in Israel for next stage clinical and regulatory development of its device together with Merz Therapeutics XEOMIN, focusing on overactive bladder treatment.
  • Merz commitment to Vensica reflects how promising the needleless treatment of patients with overactive bladder is in combination with our strategic product XEOMIN.
  • Merz Group has the businesses Merz Aesthetics, Merz Therapeutics, Merz Consumer Care, Merz Real Estate and Financial Investments.

Global Muscle Spasticity Market (2021 to 2028) - by Drug Type, Route of Administration, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, February 4, 2022

The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Muscle Spasticity Market, by Drug Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • When muscles become stiff or contract, the condition is called as muscle spasticity.
  • Muscle spasticity is seen in a variety of conditions such as spinal cord injury, brain injury, diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
  • The increasing launches of new drugs and regulatory approvals for muscle spasticity are expected to drive the market growth during the forecast period.

DETOXIFY YOUR PERSONAL CARE REGIMEN WITH THE NATURAL GROCERS® BODY CARE & BEAUTY BONANZA IN FEBRUARY 2022

Retrieved on: 
Monday, January 24, 2022

To help its communities detoxify their beauty and hygiene routines, Natural Grocers is hosting its 2nd annual Body Care & Beauty Bonanza all February long.

Key Points: 
  • To help its communities detoxify their beauty and hygiene routines, Natural Grocers is hosting its 2nd annual Body Care & Beauty Bonanza all February long.
  • Over 150 brands have passed the test of Natural Grocers' 'What We Won't Carry and Why' standards.
  • {N}power members will receive an automatic entry for every $50 spent on body care and beauty products from January 28 through February 26iii.
  • Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements.